Long-term Efficacy and Persistence of Subcutaneous Infliximab after Switching from Intravenous Infliximab in patients with Crohn's disease: A Real-World Multicenter Prospective Cohort Study in Korea

被引：0
|
作者：
Kim, K. [1 ]
Hong, S. N. [2 ]
Kang, S. B. [3 ]
Lee, K. M. [4 ]
Koo, J. S. [5 ]
Jung, Y. [6 ]
Yoon, H. [7 ]
Lee, B. J. [8 ]
Lee, H. S. [9 ]
Lee, Y. J. [10 ]
Lim, Y. J. [11 ]
Lee, J. [12 ]
Lee, C. K. [13 ]
Shin, S. Y. [14 ]
Moon, J. M. [14 ]
Seo, J. [1 ]
Lim, H. [1 ]
Choi, C. H. [1 ]
机构：
[1] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea
[3] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Internal Med, Daejeon, South Korea
[4] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med, Suwon, South Korea
[5] Korea Univ, Coll Med, Dept Internal Med, Ansan, South Korea
[6] Soonchunhyang Univ, Coll Med, Dept Internal Med, Cheonan, South Korea
[7] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
[8] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[9] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea
[10] Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea
[11] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Goyang, South Korea
[12] Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea
[13] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea
[14] Chung Ang Univ, Gwangmyeong Hosp, Dept Internal Med, Gwangmyeong, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0934
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0760
引用
收藏
页码：I1466 / I1467
页数：2
相关论文
共 50 条
  • [41] Effectiveness comparison between ustekinumab and infliximab for Crohn's disease complicated with intestinal stenosis: a multicenter real-world study
    He, Xidong
    Wang, Yufang
    Sun, Jingyao
    Li, Yueqin
    Ruan, Gechong
    Li, Yue
    Zheng, Weiyang
    Zhang, Xiaolan
    Zhan, Rongrong
    Ding, Xueli
    Liu, Ailing
    Chen, Yijia
    Hu, Yiqun
    Yang, Hong
    Qian, Jiaming
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [42] SUPERIOR TREATMENT PERSISTENCE WITH INFLIXIMAB VERSUS ADALIMUMAB IN FISTULISING CROHN'S DISEASE: REAL-WORLD REGISTRY DATA FROM THE PERSISTENCE AUSTRALIAN NATIONAL IBD COHORT (PANIC) STUDY
    Chetwood, John D.
    Paramsothy, Sudarshan
    Leong, Rupert
    GASTROENTEROLOGY, 2024, 166 (05) : S1429 - S1429
  • [43] Long-term outcome of treatment with infliximab in 440 crohn's disease patients: Results from a single center cohort
    Schnitzler, Fabian
    Fidder, Henna
    Ferrante, Marc
    Noman, Maja
    Van assche, Geri
    Hoffman, Ilse
    Vermeire, Severine
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2007, 132 (04) : A145 - A145
  • [44] SWITCHING FROM ORIGINATOR INFLIXIMAB TO BIOSIMILAR INFLIXIMAB: EFFICACY AND SAFETY IN A COHORT OF PATIENTS WITH ESTABLISHED BEHCET'S DISEASE
    Venerito, V.
    Lopalco, G.
    Cantarini, L.
    Fabiani, C.
    Nivuori, M.
    Cacciapaglia, F.
    Galeazzi, M.
    Lapadula, G.
    Iannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1494 - 1495
  • [45] A PROSPECTIVE EVALUATION OF CLINICAL OUTCOMES OF SUBCUTANEOUS INFLIXIMAB FOLLOWING INTRAVENOUS INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE
    Kim, Min Kyu
    Lee, Cheol-Hyung
    Baek, Ji Eun
    Bae, June Hwa
    Park, Jung-Bin
    Hong, Seung Wook
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    GASTROENTEROLOGY, 2024, 166 (05) : S830 - S830
  • [46] Efficacy and Safety of Different Doses of Adalimumab in Crohn's Disease: A Multicenter Cohort Study in Infliximab-Naïve and Infliximab-Exposed Patients
    Xu, Z.
    Peng, X.
    Zhi, M.
    Zhang, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1657 - i1659
  • [47] Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease
    Reenaers, Catherine
    Mary, Jean-Yves
    Nachury, Maria
    Bouhnik, Yoram
    Laharie, David
    Allez, Matthieu
    Dupas, Jean-Louis
    Amiot, Aurelien
    Savoye, Guillaume
    Altwegg, Romain
    De Vos, Martine
    Malamut, Georgia
    Boureille, Arnaud
    Flourie, Bernard
    Marteau, Philippe R.
    Vuitton, Lucine
    Coffin, Benoit
    Viennot, Stephanie
    Colombel, Jean-Frederic
    Louis, Edouard
    GASTROENTEROLOGY, 2016, 150 (04) : S72 - S72
  • [48] Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study
    Smith, P. J.
    Storey, D.
    Gregg, B.
    Critchley, L.
    Stenson, J.
    Kneebone, A.
    Rimmer, T.
    Burke, S.
    Hussain, S.
    Teoh, W. Y.
    Vazeille, S.
    Serna, S.
    Bond, A.
    Steel, A.
    Dibb, M.
    Collins, P.
    Derbyshire, E.
    Bodger, K.
    Probert, C.
    Verma, A.
    Subramanian, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S480 - S481
  • [49] THE COURSE OF INFLIXIMAB DISCONTINUATION AFTER LONG-TERM MAINTENANCE THERAPY IN CROHN'S DISEASE
    Armuzzi, A.
    Rizzi, M.
    Monterubbianesi, R.
    Marzo, M.
    Cicala, M.
    Guidi, L.
    Prantera, C.
    Kohn, A.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S135 - S135
  • [50] The Course of Infliximab Discontinuation After Long-Term Maintenance Treatment in Crohn's Disease
    Armuzzi, Alessandro
    Rizzi, Marina
    Monterubbianesi, Rita
    Marzo, Manuela
    Cicala, Michele
    Guidi, Luisa
    Prantera, Cosimo
    Kohn, Anna
    GASTROENTEROLOGY, 2010, 138 (05) : S687 - S687
12345